Cerebrospinal fluid diversion procedures

Journal of Neuro-Ophthalmology

Volumn 24, Issue 2, 2004, Pages 146-155

  Garton, Hugh J L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Taubman 2128 0220 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTOMOSIS; ANTIBIOTIC IMPREGNATED CATHETER; BLOOD PRESSURE MONITORING; BRAIN THIRD VENTRICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CATHETER; CEREBROSPINAL FLUID DIVERSION PROCEDURE; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID FLOW; CEREBROSPINAL FLUID SHUNTING; DEVICE; FLOW KINETICS; FOLLOW UP; HUMAN; HYDROCEPHALUS; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LUMBOPERITONEAL SHUNT; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SHUNTING;

CEREBROSPINAL FLUID SHUNTS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HUMANS; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; LUMBOSACRAL REGION; PERITONEUM; THIRD VENTRICLE; VENTRICULOPERITONEAL SHUNT; VENTRICULOSTOMY;

EID: 2642584971     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041327-200406000-00010     Document Type: Review

References (64)

1. Bondurant CP, Jimenez DF. Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 1995;23:254-8.
2. Greitz D, Franck A, Nordell B. On the pulsatile nature of intracranial and spinal CSF-circulation demonstrated by MR imaging. Acta Radiol 1993;34:321-8.
3. Egnor M, Rosiello A, Zheng L. A model of intracranial pulsations. Pediatr Neurosurg 2001;35:284-98.
4. Tenti G, Sivaloganathan S, Drake JM. The synchrony of arterial and CSF pulsations is not due to resonance. Pediatr Neurosurg 2002; 37:221-2.
5. Karahalios DG, Rekate HL, Khayata MH, et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46:198-202.
6. Oldfield EH, Muraszko K, Shawker TH, et al. Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg 1994;80:3-15.
7. Johnston M, Papaiconomou C. Cerebrospinal fluid transport: a lymphatic perspectiye. News Physiol Sci 2002;17:227-30.
8. Bell WO. Cerebrospinal fluid reabsorption. A critical appraisal. 1990. Pediatr Neurosurg 1995;23:42-53.
9. Di Rocco C, Marchese E, Velardi F. A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991-1992 Education Committee on the ISPN. Child's Nervous System 1994; 10:321-327.
10. Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998;43:294-303.
11. Kestle JR, Drake JM, Cochrane DD, et al. Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: a multicenter randomized trial. J Neurosurg 2003;98:284-90.
12. Pollack IF, Albright AL, Adelson PD. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery 1999;45:1399-411.
13. Buxton N, Macarthur D, Robertson I, et al. Neuroendoscopic third ventriculostomy for failed shunts. Surg Neurol 2003;60:201-4.
14. Boschert J, Hellwig D, Krauss JK. Endoscopic third ventriculostomy for shunt dysfunction in occlusive hydrocephalus: long-term follow up and review. J Neurosurg 2003;98:1032-9.
15. Kehler U, Gliemroth J. Extraventricular intracisternal obstructive hydrocephalus - a hypothesis to explain successful 3rd ventriculostomy in communicating hydrocephalus. Pediatr Neurosurg 2003; 38:98-101.
16. Decq P, Le Guerinel C, Sol JC, et al. Chiari I malformation: a rare cause of noncommunicating hydrocephalus treated by third ventriculostomy. J Neurosurg 2001;95:783-90.
17. Schwartz TH, Yoon SS, Cutruzzola FW, et al. Third ventriculostomy: postoperative ventricular size and outcome. Minim Invasive Neurosurg 1996;39:122-9.
18. Meier U, Zeilinger FS, Schonherr B. Endoscopic ventriculostomy versus shunt operation in normal pressure hydrocephalus: diagnostics and indication. Minim Invasive Neurosurg 2000;43:87-90.
19. Grunert P, Charalampaki P, Hopf N, et al. The role of third ventriculostomy in the management of obstructive hydrocephalus. Minim Invasive Neurosurg 2003;46:16-21.
20. Hopf NJ, Grunert P, Fries G, et al. Endoscopic third ventriculostomy: outcome analysis of 100 consecutive procedures [see comments]. Neurosurgery 1999;44:795-806.
21. Cinalli G, Sainte-Rose C, Chumas P, et al. Failure of third ventriculostomy in the treatment of aqueductal stenosis in children. J Neurosurg 1999;90:448-54.
22. Buxton N, Macarthur D, Mallucci C, et al. Neuroendoscopic third ventriculostomy in patients less than 1 year old. Pediatr Neurosurg 1998;29:73-6.
23. Schroeder HW, Niendorf WR, Gaab MR. Complications of endoscopic third ventriculostomy. J Neurosurg 2002;96:1032-40.
24. Barlow P, Ching HS. An economic argument in favor of endoscopic third ventriculostomy as a treatment of obstructive hydrocephalus. Minim Invasive Neurosurg 1997;40:37-9.
25. Garton HJ, Kestle JR, Cochrane DD, et al. A Cost-Effectiveness Evaluation of Endoscopic Third Ventriculostomy. In: Pediatric Section Meeting of the American Association of Neuological Surgeons. Indianapolis. 1998.
26. Zemack G, Romner B. Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients. J Neurosurg 2000;92:941-8.
27. Czosnyka Z, Czosnyka M, Copeman J, et al. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Neurosurgery 2000;47: 1250-1.
28. Kestle J, Drake J, Milner R, et al. Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000;33:230-6.
29. Hanlo PW, Cinalli G, Vandertop WP, et al. Treatment of hydrocephalus determined by the European Orbis Sigma Valve II survey: a multicenter prospective 5-year shunt survival study in children and adults in whom a flow-regulating shunt was used. J Neurosurg 2003;99:52-7.
30. Zemack G, Bellner J, Siesjo P, et al. Clinical experience with the use of a shunt with an adjustable valve in children with hydrocephalus. J Neurosurg 2003;98:471-6.
31. Tuli S, Drake J, Lawless J, et al. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg 2000;92:31-8.
32. Korinth MC, WeinzierI MR, Gilsbach JM. Experience with a new concept to lower non-infectious complications in infants with programmable shunts. Eur J Pediatr Surg 2003;13:81-6.
33. Rohde V, Weinzierl M, Mayfrank L, et al. Postshunt insertion CSF leaks in infants treated by an adjustable valve opening pressure reduction. Childs Nerv Syst 2002;18:702-4.
34. Borgbjerg BM, Gjerris F, Albeck MJ, et al. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995;136:1-7.
35. Haines SJ, Walters BC. Antibiotic Prophylaxis for Cerebrospinal Fluid Shunts: A Metanalysis. Neurosurgery 1994;34:87-93.
36. Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003;98: 725-30.
37. Gucer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg 1978;49: 256-63.
38. Maartens NF, Lustgarten L, Josan V, et al. How safe is twistdrill craniostomy? Br J Neurosurg 2002;16:290-3.
39. Pearson PA, Baker RS, Khorram D, et al. Evaluation of optic nerve sheath fenestration in pseudotumor cerebri using automated perimetry. Ophthalmology 1991;98:99-105.
40. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997;49:734-9.
41. Cornblath WT, Miller NR. Pseudotumor Cerebri Treated with Lumboperitoneal Shunt [Abstract]. Ann Neurol 1989;26:183.
42. Lueck C, Mcllwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2002:CD003434.
43. Rosenberg ML, Corbett JJ, Smith C, et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993;43: 1071-2.
44. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996;46: 1524-30.
45. Tulipan N, Lavin PJ, Copeland M. Stereotactic ventriculoperitoneal shunt for idiopathic intracranial hypertension: technical note. Neurosurgery 1998;43:175-7.
46. Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatry 1994;57:1426-9.
47. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1993;111:632-5.
48. Corbett JJ, Nerad JA, Tse DT, et al. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol 1988;106:1391-7.
49. Herzau V, Baykal HE. Long-term outcome of optic nerve sheath fenestration in pseudotumor cerebri (in German). Klin Monatsbl Augenheilkd 1998;213:154-60.
50. Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988;106: 1378-83.
51. Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 2000;107:1907-12.
52. Kelman SE, Heaps R, Wolf A, et al. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri. Neurosurgery 1992;30:391-5.
53. Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol 1997;17:86-91.
54. Mauriello JA, Jr, Shaderowfsky P, Gizzi M, et al. Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri. Ophthalmology 1995;102:441-5.
55. Magnaes B. Body position and cerebrospinal fluid pressure. Part 2: clinical studies on orthostatic pressure and the hydrostatic indifferent point. J Neurosurg 1976;44:698-705.
56. Chumas PD, Armstrong DC, Drake JM, et al. Tonsillar herniation: the rule rather than the exception after lumboperitoneal shunting in the pediatric population. J Neurosurg 1993;78:568-73.
57. Chumas PD, Drake JM, Del Bigio MR. Death from chronic tonsillar herniation in a patient with lumboperitoneal shunt and Crouzon's disease. Br J Neurosurg 1992;6:595-9.
58. Rekate HL, Wallace D. Lumboperitoneal shunts in children. Pediatr Neurosurg 2003;38:41-6.
59. Hart A, David K, Powell M. The treatment of 'acquired tonsillar herniation' in pseudotumor cerebri. Br J Neurosurg 2000;14: 563-5.
60. Sullivan LP, Stears JC, Ringel SP. Resolution of syringomyelia and Chiari I malformation by ventriculoatrial shunting in a patient with pseudotumor cerebri and a lumboperitoneal shunt. Neurosurgery 1988;22:744-7.
61. Johnston I, Jacobson E, Besser M. The acquired Chiari malformation and syringomyelia following spinal CSF drainage: a study of incidence and management. Acta Neurochir (Wien) 1998;140: 417-28.
62. Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999;127:178-82.
63. O'Leary ST, Kole MK, Hoover DA, et al. Efficacy of the Ghajar Guide revisited: a prospective study. J Neurosurg 2000;92: 801-3.
64. Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988;106:1384-90.